Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tiziana Life Sciences PLC

1.16
+0.07506.94%
Volume:291.52K
Turnover:330.60K
Market Cap:120.12M
PE:-8.66
High:1.18
Open:1.04
Low:1.04
Close:1.08
Loading ...

‘Time to Pull the Plug,’ Says Top Investor About Tesla Stock

TIPRANKS
·
24 Feb

BRIEF-Tiziana Life Sciences Announces Agreement With Renaissance Lakewood

Reuters
·
21 Feb

BRIEF-Tiziana Life Sciences Announces Agreement For Product Development Services With Renaissance Lakewood, Llc

Reuters
·
21 Feb

Tiziana Life Sciences Teams Up With Renaissance Lakewood on Nasal Drug Delivery

MT Newswires Live
·
21 Feb

Tiziana enters product development services agreement with Renaissance

TIPRANKS
·
21 Feb

Tiziana Life Sciences Ltd: Collaboration Aims to Develop a Comprehensive Plan for Scale-up of Foralumab in a Nasal Device

THOMSON REUTERS
·
21 Feb

Tiziana Life Sciences Announces Agreement for Product Development Services With Renaissance Lakewood, Llc

THOMSON REUTERS
·
21 Feb

Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC

GlobeNewswire
·
21 Feb

Tiziana Life Sciences doses additional four patients in multiple sclerosis trial

TIPRANKS
·
18 Feb

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

THOMSON REUTERS
·
18 Feb

3 Promising US Penny Stocks With Market Caps Over $20M

Simply Wall St.
·
12 Feb

Tiziana announces TV interview with AD patient dosed with foralumab

TIPRANKS
·
11 Feb

Tiziana Life Sciences Announces Tv Interview With First Patient Dosed With Moderate Alzheimer’s Disease

THOMSON REUTERS
·
11 Feb

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease

GlobeNewswire
·
11 Feb

Tiziana Life Sciences Shares Higher on Positive Results for Spinal Cord Injury Treatment

Dow Jones
·
24 Jan

Tiziana Life Sciences' Foralumab Demonstrates Motor Function Improvement in Preclinical Spinal Cord Injury Studies

MT Newswires Live
·
24 Jan